Hepatic molecular characteristics of patients with varying degrees of nonalcoholic steatohepatitis compared to healthy normal weight individuals
American Journal of Physiology - Gastroenterology and Liver Physiology 316(4):G462-G472, 2019
Disease progression and pharmacological intervention in a nutrient-deficient rat model of nonalcoholic steatohepatitis
Digestive Diseases and Sciences 64(5):1238-1256, 2019
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafbranor in diet-induced obese mouse models of biopsy-confrmed nonalcoholic steatohepatitis
World Journal of Gastroenterology 24(2):179–194, 2018
INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
World Journal of Gastroenterology 24(2):195–210, 2018
In-vitro and in-vivo studies supporting the therapeutic potential of ZP3022 in diabetes
European Journal of Pharmacology 815:181–189, 2017
Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy
World Journal of Hepatology 8(16):673-684, 2016